ProDGNE is a collaborative effort combining patient experience, complementary, and synergist expertise in glycobiology, biochemistry, medicinal chemistry, clinical pharmacology, -omics, biomarker discovery, pharmaceutical technology and clinical expertise to develop proof of principle of novel attractive compounds to treat GNE Myopathy (GNEM) and bring lead compounds one step closer to patients.